» Authors » Sudipta Chattopadhyay

Sudipta Chattopadhyay

Explore the profile of Sudipta Chattopadhyay including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 218
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chattopadhyay S, Adjei F, Kardos A
J Cardiovasc Transl Res . 2024 Feb; 17(4):870-878. PMID: 38349586
Cardiac electrical biomarker (CEB), an indicator of ischaemia-induced change in myocyte polarity, has been proposed for diagnosis of acute coronary syndrome. However, effect of coronary occlusion on CEB has not...
2.
Chughtai A, Dey R, Chattopadhyay S
J Vasc Access . 2021 Apr; 23(5):822-824. PMID: 33845668
We present a case of the catastrophic bleeding from the femoral access site after an uncomplicated puncture in a patient with Type 1 osteogenesis imperfecta (OI) undergoing coronary angiogram via...
3.
4.
Agarwal M, How L, Chattopadhyay S, Kardos A
Lancet . 2021 Jan; 397(10269):128. PMID: 33422246
No abstract available.
5.
Shaikh O, Zidros S, Chattopadhyay S
Eur Heart J . 2020 Oct; 41(46):4447. PMID: 33029627
No abstract available.
6.
Chattopadhyay S, George A, John J, Sathyapalan T
J Diabetes . 2020 Sep; 13(3):191-199. PMID: 32910560
Background: The effect of postload glucose spikes (PGS), the difference between 2 hour post-load plasma glucose (2hPLPG) and fasting plasma glucose (FPG), on post-myocardial infarction (post-MI) prognosis in nondiabetic patients...
7.
Chattopadhyay S, George A, John J, Sathyapalan T
Cardiology . 2020 Aug; 145(9):553-561. PMID: 32784310
Objective: To assess improvement in predictive performance of Global Registry of Acute Coronary Events risk score (GRS) by addition of a glucose matrix. Methods: 1,056 acute coronary syndrome (ACS) survivors...
8.
Chattopadhyay S, George A, John J, Sathyapalan T
J Diabetes Complications . 2020 Jan; 34(4):107518. PMID: 31924528
Aims: Investigate if abnormal glucose tolerance (AGT) affects post-myocardial infarction (MI) prognosis in patients with hospital-related hyperglycaemia (HRH) but without known diabetes mellitus (KDM). Methods: Post-MI survivors without KDM underwent...
9.
10.
Choudhury A, Garg S, Smith J, Sharp A, Nabais de Araujo S, Chauhan A, et al.
BMJ Open . 2019 Oct; 9(10):e026578. PMID: 31604782
Objective: To prospectively evaluate safety and efficacy of the ultrathin strut biodegradable polymer-coated Supraflex sirolimus-eluting stent (S-SES) in 'real world' patient population requiring percutaneous coronary intervention (PCI). Methods: National, prospective,...